M&A Deal Summary

KeraVision Acquires Transcend Therapeutics

On June 3, 1999, KeraVision acquired life science company Transcend Therapeutics from Advent International for 8M USD

Acquisition Highlights
  • This is KeraVision’s 1st transaction in the Life Science sector.
  • This is KeraVision’s largest (disclosed) transaction.
  • This is KeraVision’s 1st transaction in the United States.
  • This is KeraVision’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 1999-06-03
Target Transcend Therapeutics
Sector Life Science
Buyer(s) KeraVision
Sellers(s) Advent International
Deal Type Add-on Acquisition
Deal Value 8M USD

Target

Transcend Therapeutics

Waltham, Massachusetts, United States
Transcend Therapeutics, Inc. is a developer of novel pharmaceuticals for the critical-care market in US.

Search 197,704 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

KeraVision

Fremont, California, United States
Category Company
Founded 1996
Sector Healthcare Services
DESCRIPTION

KeraVision, Inc. manufactures non-laser vision correction products.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (1999) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Advent International

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1984
PE ASSETS 76.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Advent is a global private equity firm that targets investments in North America, Europe, Asia, and Latin America. Advent's emerging market efforts are concentrated in Central Europe and Latin America. Advent seeks transactions valued between $50 million and $5 billion and can commit up to $2 billion of equity capital per investment. Broad areas of interest include business & financial services, retail & consumer, technology, media, & telecoms, healthcare & life sciences, and industrial. Prospective transaction types include buyouts, growth capital financings, take privates, and recapitalizations. Advent was formed in 1984 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 15 of 220
Sector (Life Science) 1 of 12
Type (Add-on Acquisition) 8 of 81
State (Massachusetts) 4 of 16
Country (United States) 8 of 80
Year (1999) 6 of 14
Size (of disclosed) 52 of 52
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-06-02 Trinity Pharmaceuticals

Cheadle, United Kingdom

Trinity Pharmaceuticals Ltd. originates, co-develops, licenses and markets a range of own brand pharmaceuticals through its national sales force.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
1999-07-01 Thomson Directories

Farnborough, United Kingdom

Thomson Directories Limited publishes business listings in print and online formats.

Sell -
Mergr

Product

Company

Legal